Diabetology and USV in licensing accord for oral insulin for the Indian market
12:33 EDT 1 Aug 2012 | thePharmaLetter
UK-based Diabetology Limited and Mumbai, India-based USV Limited, which has a leadership position in the Indian oral anti-diabetic market, have entered into a licence agreement to complete the development and commercialization of Diabetology's oral i..
Original Article: Diabetology and USV in licensing accord for oral insulin for the Indian market
More From BioPortfolio on "Diabetology and USV in licensing accord for oral insulin for the Indian market"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
